We are happy to announce successful integration with our foreign partner, Applied Neuroscience, Inc...

Depression is recognized as a common mental disorder. It is estimated that 5% of adults, or 350 million people around...

Acute stroke, “brain attack”, or cerebrovascular accident is the 5th leading cause of death and the 1st...

We invite you to Step Up!

If you have an idea for your research project but have no resources for its...

On January 29-30, 2022, in Jakarta (Gandaria City), Indonesia, the training courses in quantitative EEG with...

They say life just begins after thirty. And it's true! At this stage, Neurosoft is already full of experience,...

"The best way to predict the future is to create it" — this saying of Abraham Lincoln captures best the...

The XXIX International Congress of Neurology and Neurosurgery was held in the Dominican Republic from October 14 to 17....

Walking function disorders are typical for patients after cerebral stroke. Biofeedback technology (BFB) is currently...

This year Australian researchers conducted a three arm, single blind, randomised, controlled, multi-site trial...

Neurosoft devices are scattered all over the world. Recently we reported about the first deliveries of the new...

Dear friends, with great pleasure and enormous pride, we want to inform you that the multimodular system...